Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 HDAC6 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
2 HDAC5 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
3 CDK4 [1] Viral carcinogenesis D10688 Abemaciclib [1] 34
4 CDK6 [1] Viral carcinogenesis D10688 Abemaciclib [1] 34
5 CCR4 [2] Viral protein interaction with cytokine and cytokine receptor, Viral carcinogenesis D09761 Mogamulizumab [1] 26
6 CCR5 [4] Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Viral protein interaction with cytokine and cytokine receptor, Viral carcinogenesis D06670 Maraviroc [2] 46, 84
7 CCR5 [4] Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Viral protein interaction with cytokine and cytokine receptor, Viral carcinogenesis D09878 Cenicriviroc [1] 94
8 HDAC1 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
9 HDAC2 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
10 JAK1 [1] Viral carcinogenesis D09959 Ruxolitinib [3] 60, 65, 228
11 JAK1 [1] Viral carcinogenesis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
12 JAK1 [1] Viral carcinogenesis D10308 Baricitinib [13] 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
13 JAK1 [1] Viral carcinogenesis D10653 Peficitinib [1] 46
14 JAK1 [1] Viral carcinogenesis D10871 Filgotinib [6] 46, 53, 96, 97, 222, 271
15 JAK1 [1] Viral carcinogenesis D10944 Itacitinib [4] 46, 51, 97, 228
16 JAK1 [1] Viral carcinogenesis D10994 Upadacitinib [8] 40, 41, 46, 49, 96, 97, 107, 271
17 JAK1 [1] Viral carcinogenesis D11400 Abrocitinib [1] 84
18 JAK3 [1] Viral carcinogenesis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
19 JAK3 [1] Viral carcinogenesis D10653 Peficitinib [1] 46
20 NFKB1 [2] Yersinia infection, Viral carcinogenesis D01146 Iguratimod [5] 46, 51, 53, 271, 300
21 HDAC7 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
22 PIK3CA [2] Yersinia infection, Viral carcinogenesis D11011 Alpelisib [1] 138
23 PIK3CA [2] Yersinia infection, Viral carcinogenesis D11158 Leniolisib [2] 53, 65
24 PIK3CB [2] Yersinia infection, Viral carcinogenesis D11158 Leniolisib [2] 53, 65
25 PIK3CD [2] Yersinia infection, Viral carcinogenesis D11158 Leniolisib [2] 53, 65
26 PIK3CD [2] Yersinia infection, Viral carcinogenesis D11437 Parsaclisib [3] 35, 53, 61
27 HDAC8 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
28 RELA [2] Yersinia infection, Viral carcinogenesis D12181 Edasalonexent [1] 113
29 SRC [2] Yersinia infection, Viral carcinogenesis D03252 Bosutinib [2] 2, 67
30 SRC [2] Yersinia infection, Viral carcinogenesis D03658 Dasatinib [2] 51, 85
31 SRC [2] Yersinia infection, Viral carcinogenesis D06414 Dasatinib [2] 51, 85
32 SRC [2] Yersinia infection, Viral carcinogenesis D09664 Saracatinib [3] 6, 89, 272
33 SYK [1] Viral carcinogenesis D09347 Fostamatinib [4] 46, 49, 61, 66
34 C3 [1] Viral carcinogenesis D11613 Pegcetacoplan [4] 2, 61, 62, 222
35 HDAC11 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
36 HDAC10 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
37 HDAC3 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
38 HDAC9 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96
39 HDAC4 [1] Viral carcinogenesis D06320 Vorinostat [2] 75, 96